New application for pien tze huang and preparation thereof in aspect of protecting memory function and resisting cerebral ischemia

Abstract

The invention discloses new application for pien tze huang in the aspect of protecting a memory function and resisting cerebral ischemia. The pien tze huang belongs to a traditional first-grade state-protection traditional Chinese medicine, is processed and prepared into various types of conventional formulations applied clinically, has effects of inflammation diminishing, cooling, detoxication, detumescence, pain relieving and the like, has good curative effects for diseases of pain, fever and the like caused by oxyhepatitis, ophthalmia, otitis and all inflammations, and further has an obvious inhibiting effect for cancer cells of the digestive system of a patient. The pien tze huang in the invention has a remarkable effect in the aspect of protecting the memory function and resisting cerebral ischemia. In addition, preventive therapy by the aid of the pien tze huang can relieve apoplexy severity and prolong survival life of patients with apoplexy, and simultaneously, the effect of the pien tze huang is confirmed. Mechanism research of the new application for the pien tze huang is realized, and accordingly, the new application for the pien tze huang has a more scientific basis.

Description

field of invention [0001] The invention relates to a new application of a pharmaceutical composition, in particular to a new application of Pien Tze Huang and its preparation in protecting memory function and resisting cerebral ischemia. Background technique [0002] Transient ischemic attack is a kind of common acute cerebrovascular disease, which is called a stroke in traditional Chinese medicine. Sudden onset of the disease, similar to cerebral hemorrhage or cerebral infarction, usually fully returns to normal within 24 hours, often causing false alarms in family members, but can recur. Patients with transient ischemic attack may develop cerebral infarction within 1 to 5 years. However, 1 / 3 to 2 / 3 of the patients with cerebral infarction had a transient ischemic attack. According to reports, about 1 / 2 to 3 / 4 of the patients with transient ischemic attack develop cerebral infarction within 3 years. After treatment, the transient ischemic attack can be terminated, or 79.6...

AI Technical Summary

Problems solved by technology

At present, there is no relevant report on the protection of memory function and anti-cerebral ischemia of Pien Tze Huang.

Images